177 related articles for article (PubMed ID: 2949362)
1. [Effects of perfusion of human atrial natriuretic factor in normal volunteers].
Bidiville J; Waeber G; Nussberger J; Biollaz J; Porchet M; Waeber B; Brunner HR
Schweiz Med Wochenschr; 1986 Dec; 116(49):1733-5. PubMed ID: 2949362
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.
Bidiville J; Waeber G; Porchet M; Nussberger J; Biollaz J; Gomez H; Callahan L; Waeber B; Brunner HR
Fundam Clin Pharmacol; 1988; 2(5):413-29. PubMed ID: 2976727
[TBL] [Abstract][Full Text] [Related]
3. [Effect of synthetic atrial natriuretic factors on various regional blood flows in the healthy subject].
Biollaz J; Waeber G; Jaggi C; Waeber B; Nussberger J; Brunner HR
Arch Mal Coeur Vaiss; 1986 Jun; 79(6):961-6. PubMed ID: 2948474
[TBL] [Abstract][Full Text] [Related]
4. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
[TBL] [Abstract][Full Text] [Related]
5. Systemic and renal effects of atrial natriuretic peptide in patients with heart failure treated with angiotensin-converting enzyme inhibitor or in acute saline solution loading.
Tomiyama H; Watanabe G; Abe M; Okazaki R; Yoshida H; Doba N
Am Heart J; 2001 Mar; 141(3):422-7. PubMed ID: 11231440
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of atrial natriuretic (3-28) eicosahexapeptide.
Biollaz J; Nussberger J; Waeber B; Brunner HR
J Hypertens Suppl; 1986 Jun; 4(2):S101-8. PubMed ID: 2941530
[TBL] [Abstract][Full Text] [Related]
7. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
Eiskjaer H; Nielsen CB; Pedersen EB
J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide attenuates pressor but enhances natriuretic responses to angiotensin II in pregnant conscious goats.
Olsson K; Hossaini-Hilali J; Eriksson L
Acta Physiol Scand; 1992 Aug; 145(4):385-94. PubMed ID: 1388314
[TBL] [Abstract][Full Text] [Related]
9. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure].
Fontana F; Guardigli G; Cappelli M; Bernardi P
G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692
[TBL] [Abstract][Full Text] [Related]
10. Measurement of changes in glomerular filtration rate induced by atrial natriuretic peptide in the rat kidney.
Caron N; Kramp R
Exp Physiol; 1999 Jul; 84(4):689-96. PubMed ID: 10481226
[TBL] [Abstract][Full Text] [Related]
11. The effects of atrial natriuretic peptide on renal function and the renin-aldosterone system in anesthetized rabbits.
Nushiro N; Abe K; Seino M; Itoh S; Yoshinaga K
Tohoku J Exp Med; 1987 Jul; 152(3):301-10. PubMed ID: 2958960
[TBL] [Abstract][Full Text] [Related]
12. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
Bauer WR; Neubauer S; Obitz G; Ertl G
J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
[TBL] [Abstract][Full Text] [Related]
13. Relationship of the renin-angiotensin system and systemic arterial pressure to sodium excretion during atrial natriuretic peptide infusion in men.
Grandis DJ; Uretsky BF; Verbalis JG; Chong TK; Puschett JB
Am J Hypertens; 1992 Nov; 5(11):793-9. PubMed ID: 1457079
[TBL] [Abstract][Full Text] [Related]
14. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
Cerasola G; Cottone S; Mangano MT; D'Ignoto G; Pinto A; Carone MB
Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic peptide induces sustained natriuresis in conscious dogs.
Mizelle HL; Hildebrandt DA; Gaillard CA; Brands MW; Montani JP; Smith MJ; Hall JE
Am J Physiol; 1990 Jun; 258(6 Pt 2):R1445-52. PubMed ID: 2141770
[TBL] [Abstract][Full Text] [Related]
16. [Does atrial antipressor natriuretic peptide play a pathophysiological role?].
Bühler FR
Schweiz Med Wochenschr; 1987 Dec; 117(49):1930-7. PubMed ID: 2962281
[TBL] [Abstract][Full Text] [Related]
17. Renal effects of synthetic rat-atrial natriuretic peptide in nephron-reduced rats with nephrotoxic nephritis.
Nitta K; Sanaka T; Kawaguchi H; Tsuchiya K; Sone M; Takuma T; Sugino N
Jpn J Exp Med; 1987 Feb; 57(1):41-5. PubMed ID: 2957529
[TBL] [Abstract][Full Text] [Related]
18. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
[TBL] [Abstract][Full Text] [Related]
19. Captopril reduces the renal response to intravenous atrial natriuretic peptide in normotensives.
Wilkins MR; Lewis HM; West MJ; Kendall MJ; Lote CJ
J Hum Hypertens; 1987 Jun; 1(1):47-51. PubMed ID: 2977404
[TBL] [Abstract][Full Text] [Related]
20. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
